Targeting dopaminergic neuronal death: Luteolin as a therapeutic modulator in Parkinson's disease.

Chib S, Dutta BJ, Singh G, Singh R, Singh S

DOI: 10.1007/s13205-025-04267-9
Published: 2025 May
Container: 3 Biotech
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13205-025-04267-9,
  title = {Targeting dopaminergic neuronal death: Luteolin as a therapeutic modulator in Parkinson's disease.},
  author = {Chib S and Dutta BJ and Singh G and Singh R and Singh S},
  year = {2025},
  journal = {3 Biotech},
  doi = {10.1007/s13205-025-04267-9},
  url = {https://doi.org/10.1007/s13205-025-04267-9}
}

RIS

TY  - JOUR
TI  - Targeting dopaminergic neuronal death: Luteolin as a therapeutic modulator in Parkinson's disease.
AU  - Chib S
AU  - Dutta BJ
AU  - Singh G
AU  - Singh R
AU  - Singh S
PY  - 2025
JO  - 3 Biotech
DO  - 10.1007/s13205-025-04267-9
UR  - https://doi.org/10.1007/s13205-025-04267-9
ER  -

APA

S, C., BJ, D., G, S., R, S., & S, S. (2025). Targeting dopaminergic neuronal death: Luteolin as a therapeutic modulator in Parkinson's disease.. 3 Biotech. https://doi.org/10.1007/s13205-025-04267-9

Source records

pubmed · retrieved 2026-09-27T07:32:09.099Z